Jonathan Barratt

Active 1999–2025

175
Papers
21,088
Citations
74
h-index
162
i10-index

Citations

Citations per year for Jonathan Barratt1994: 1 citations2000: 4 citations2001: 6 citations2002: 3 citations2003: 4 citations2004: 10 citations2005: 12 citations2006: 11 citations2007: 22 citations2008: 27 citations2009: 17 citations2010: 33 citations2011: 55 citations2012: 77 citations2013: 43 citations2014: 48 citations2015: 64 citations2016: 75 citations2017: 80 citations2018: 82 citations2019: 361 citations2020: 548 citations2021: 562 citations2022: 588 citations2023: 854 citations2024: 1,664 citations2025: 847 citations2026: 32 citations1995–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 995 citing papers, 16.3% of this breakdownChina: 868 citing papers, 14.3% of this breakdownUnited Kingdom: 526 citing papers, 8.6% of this breakdownGermany: 344 citing papers, 5.7% of this breakdownItaly: 344 citing papers, 5.6% of this breakdownJapan: 271 citing papers, 4.5% of this breakdownFrance: 236 citing papers, 3.9% of this breakdownCanada: 218 citing papers, 3.6% of this breakdownNetherlands: 201 citing papers, 3.3% of this breakdownAustralia: 179 citing papers, 2.9% of this breakdownSpain: 176 citing papers, 2.9% of this breakdownSweden: 123 citing papers, 2% of this breakdown
0%16.3%Other 26.4%

Fields

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Immunology and Microbiology7.2%
  • Computer Science2.1%
  • Health Professions0.8%
  • Chemistry0.6%
  • Other2.3%

Topics

  • Renal Diseases and Glomerulopathies16.5%
  • Chronic Kidney Disease and Diabetes8.4%
  • Vasculitis and related conditions5.7%
  • Complement system in diseases3%
  • Systemic Lupus Erythematosus Research2.8%
  • Dialysis and Renal Disease Management2.3%
  • Other61.3%

Coauthors

All papers

Open in search
  1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2021 cited by 2,416

  2. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 cited by 791

  3. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Fernanda Soares, Yusuke Suzuki, Katsuo Takahashi, Stéphan Troyanov, Jacobien C. Verhave, Suxia Wang, Jan J. Weening, Robert Wyatt, Nori Yoshikawa, Caihong Zeng - Kidney International 2017 cited by 1,171

  4. Long-Term Outcomes in IgA Nephropathy

    Authors: , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2023 cited by 394

  5. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Muh Geot Wong, Vlado Perkovic, Isabella Abbasciano, Catarina Abrantes, Simone Accarino, Sharon G. Adler, Annika Adoberg, Rouzbeh Afsari, Syeda B. Ahmad, Jafar Ahmed, Wooin Ahn, Bamidele Ajayi, Dariusz Aksamit, Saif Al‐Chalabi, É. Alamartine, Bassam Alchi, Mohammad Ali, Roberta Aliotta, Salem Almaani, Catarina Almeida, Edgar Almeida, Francisco de la Prada Álvarez, Patrícia Marques‐Alves, Francesca Annese, Gerald B. Appel, Gerald Appel, Maria Arena, Marta Calvo Arevalo, Dariush Arfaania, Carlos Arias, Emma Calatayud Aristoy, Eglė Ašakienė, Sarah Ashley, Ali Assefi, Alba Atenza, Asta Auerbach, Hanna Augustyniak‐Bartosik, Hanna Augustyniak-Bartosik, Jonathan Ayling-Smith, Isabelle Ayoub, Isabelle Ayoub, Rocco Baccaro, Asha Bailey, Bruce Baker, Saravanan Balamuthusamy, José Ballarín, Rui Barata, Jerko Barbić, Dunja Barisic, Jonathan Barratt, José C. Barreto, Clara Barrios, Mirco Belingheri, Anna Benesova, Ana Ávila Bernabéu, Wanja Bernhardt, Shamik Bhadra, Luigi Biancone, Anne Blanchard, Elena Boaglio, Davide Bolignano, Andrew S. Bomback, Gustavo Andres Useche Bonilla, M Bordoli, Bhadran Bose, Neil Boudville, Donald Brandon, Donald Brandon, Karen Brown, C Broyet and 634 more - The Lancet 2023 cited by 267

  6. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

    Authors: , , , , , , , , , , , - The Lancet 2023 cited by 289

  7. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 196

  8. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mai Rosenberg, Brad H. Rovin, Sydney Tang, Vladmir Tesar, Muh Geot Wong, Bhadran Bose, Muralikrishna Gangadharan, Stephen P. McDonald, Chen Au Peh, Sadia Jahan, Chii Yeap, Philip A. Clayton, Georgina Irish, Nikhil Thyagarajan, Peter Hollett, Rathika Krishnasamy, Robert J. Carroll, Shilpanjali Jesudason, Susan Crail, Toby Coates, Jane Waugh, Euan Noble, Kumaradevan Mahadevan, Victoria Campbell, Tania Salehi, Wai H. Lim, Neil Boudville, Aron Chakera, Doris Chan, Anoushka Krishnan, Yusuf Eqbal, Alastair Gillies, Eswari Vilayur, Thida Maung Myint, Nicholas A. Gray, Jane Waugh, Euan Noble, Melissa S Cheetham, Yusuf Eqbal, Peter Hollett, Rathika Krishnasamy, Kumaradevan Mahadevan, Victoria Campbell, Carol A. Pollock, Bruce A. Cooper, Amanda Mather, Sarah Roxburgh, Yvonne Shen, Stefanie Stangenberg, Amanda Siriwardana, Emma O’Lone, Susan Wan, Brendon L. Neuen, Jeffrey T. Ha, Dana Kim, Lauren Heath, Arunima Jain, Elaine Phua, Li Yan, M. W. Gallagher, Meg Jardine, Angus Ritchie, Mona Razavian, Celine Foote, Roger Wyndham, Shaundeep Sen, Zoltán Endre, Jonathan Erlich, Mangalee Fernando, Kenneth Yong and 631 more - The Lancet 2023 cited by 215

  9. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

    Authors: , , , , , , , , , , , , , , , , - Clinical Journal of the American Society of Nephrology 2019 cited by 288

  10. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala and 59 more - Kidney International 2022 cited by 215

  11. Next-Generation Morphometry for pathomics-data mining in histopathology

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 132

  12. Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy

    Authors: , , , , , , , , , , , , , , , - Kidney International 2023 cited by 121

  13. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Chi Bon Leung, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang - Kidney International 2009 cited by 1,236

  14. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gianluca Caridi, Monica Bodria, Francesca Lugani, Landino Allegri, Marco Delsante, Mariarosa Maiorana, Andrea Magnano, Giovanni M. Frascà, Emanuela Boer, Giuliano Boscutti, Claudio Ponticelli, Renzo Mignani, Carmelita Marcantoni, Domenico Di Landro, Domenico Santoro, Antonello Pani, Rosaria Polci, Sandro Feriozzi, Silvana Chicca, Marco Galliani, Maddalena Gigante, Loreto Gesualdo, Pasquale Zamboli, Giovanni Giorgio Battaglia, Maurizio Garozzo, Dita Maixnerová, Vladimı́r Tesař, Frank Eitner, Thomas Rauen, Jürgen Floege, Tibor Kovács, Judit Nagy, Krzysztof Mucha, Leszek Pączek, Marcin Zaniew, Małgorzata Mizerska-Wasiak, Maria Roszkowska–Blaim, Krzysztof Pawlaczyk, Daniel P. Gale, Jonathan Barratt, Lise Thibaudin, F. Berthoux, Guillaume Canaud, Anne Boland, Marie Metzger, Ulf Panzer, Hitoshi Suzuki, Shin Goto, Ichiei Narita, Yaşar Çalışkan, Jingyuan Xie, Ping Hou, Nan Chen, Hong Zhang, Robert Wyatt, Jan Novák, Bruce A. Julian, John Feehally, Bénédicte Stengel, Daniele Cusi, Richard P. Lifton, Ali G. Gharavi - Nature Genetics 2014 cited by 626

  15. IgA nephropathy

    Authors: , , , , , , , - Nature Reviews Disease Primers 2023 cited by 207

  16. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takayuki Hamano, Chuan‐Ming Hao, Raymond K. Hsu, Kunitoshi Iseki, Isabelle Jordans, Edgar V. Lerma, Francesco Locatelli, Iain C. Macdougall, Jolanta Małyszko, Patrick H. Maxwell, Lawrence P. McMahon, Gregorio T. Obrador, Marlies Ostermann, Roberto Pecoits‐Filho, Farzana Perwad, Simon D. Roger, Ajay Singh, Laura Solá, Bruce Spinowitz, Mai Sugahara, Toshiyuki Takahashi, Mototsugu TANAKA, Tetsuhiro Tanaka, Der‐Cherng Tarng, Marcello Tonelli, Yusuke Tsukamoto, Carl P. Walther, Angela Yee‐Moon Wang, Hong Kong, Bradley A. Warady, Angela C Webster, Matthew R. Weir, Jay B. Wish, Muh Geot Wong - Kidney International 2023 cited by 136

  17. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy

    Authors: , , , , , , , , , , , , , - Kidney International 2024 cited by 117

  18. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Damjan Vukcevic, Mohammed Akil, Jonathan Barratt, Neil Basu, Adam S. Butterworth, Ian N Bruce, Michael Clarkson, Niall Conlon, Bhaskar Dasgupta, Timothy Doulton, Georgina Espígol‐Frigolé, Oliver Floßmann, Armando Gabrielli, Jolanta Gąsior, Gina Gregorini, Giuseppe Guida, José Hernández‐Rodríguez, Zdenka Hrušková, Amy W. Hudson, Ann Knight, Peter Lanyon, Raashid Luqmani, Malgorzata Magliano, Angelo A. Manfredi, Christopher Marguerie, Federica Maritati, Chiara Marvisi, Neil McHugh, Eamonn Molloy, Allan Motyer, Chetan Mukhtyar, Leonid Padyukov, Alberto Pesci, Sergio Prieto‐González, Marc Ramentol-Sintas, Petra Reis, Dario Roccatello, Patrizia Rovere‐Querini, Carlo Salvarani, Francesca Santarsia, Roser Solans‐Laqué, Nicole Soranzo, Jo Taylor, Julie Wessels, Jochen Zwerina, Benjamin Terrier, Richard A. Watts, Augusto Vaglio, Julia U. Holle, Chris Wallace, Kenneth G. C. Smith - Nature Communications 2019 cited by 271

  19. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Maria Asunis, Jonathan Barratt, Regina Tardanico, Agnieszka Perkowska‐Ptasińska - Kidney International 2014 cited by 496

  20. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 105

  21. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 402

  22. Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

    Authors: , , , , , , , , - Kidney International Reports 2022 cited by 92

  23. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Sansom, Andy G. Lynch, Karyn Mégy, Eva Ellinghaus, David Ellinghaus, Silje F. Jørgensen, Tom H. Karlsen, Kathleen Stirrups, Antony J. Cutler, Dinakantha Kumararatne, Anita Chandra, David Edgar, Archana Herwadkar, Nichola Cooper, Sofia Grigoriadou, Aarnoud Huissoon, Sarah Goddard, Stephen Jolles, Catharina Schuetz, Felix Boschann, Stephen Abbs, Zoe Adhya, Julian Adlard, Maryam Afzal, Irshad Ahmed, Munaza Ahmed, Saeed Ahmed, Timothy J. Aitman, Hana Alachkar, Jayanthi Alamelu, Raza Alikhan, Carl E. Allen, Louise Allen, David Allsup, Arif Alvi, Gautam Ambegaonkar, Ariharan Anantharachagan, Philip Ancliff, Julie A. Anderson, Richard Antrobus, Ruth Armstrong, Gavin Arno, Gururaj Arumugakani, Rita Arya, Sofie Ashford, William J. Astle, Anthony Attwood, Steve Austin, Yeşim Aydınok, Waqar Ayub, Christian Babbs, Chiara Bacchelli, Trevor Baglin, Tamam Bakchoul, Tadbir K. Bariana, Jonathan Barratt, Julian Barwell, John Baski, Rachel W. Bates, Joana Batista, Helen E. Baxendale, Gareth Baynam, David Bennett, Claire Bethune, Neha Bhatnagar, Shahnaz Bibi, Agnieszka Bierżyńska, Tina Biss, Maria Bitner‐Glindzicz, Marta Bleda and 535 more - Nature 2020 cited by 242

  24. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Görlich, Mark Haas, Alister Humphreys, Vivekanand Jha, Arenn Jauhal, David Kavanagh, Andreas Kronbichler, Richard Lafayette, Lynne D. Lanning, Mathieu Lemaire, Moglie Le Quintrec, Christoph Licht, Adrian Liew, Steve McAdoo, Nicholas Medjeral‐Thomas, Pier Luigi Meroni, Johann Morelle, Carla Nester, Manuel Praga, Raja Ramachandran, Heather N. Reich, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, Gary Robinson, Pierre Ronco, Peter Rossing, David J. Salant, Sanjeev Sethi, Marianne Silkjaer, Wen‐Chao Song, Fabrizio Spoleti, Ronald P. Taylor, Nicole C. A. J. van de Kar, Cees van Kooten, Len Woodward, Yuzhou Zhang, Peter F. Zipfel, Marco Zuccato - Kidney International 2024 cited by 125